Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Repligen (NASDAQ: RGEN)
Follow
NASDAQ:RGEN
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
RGEN
Repligen
Garland Jason K
/
officer: CFO
03/03/2025
Buy
$155.38
6,056
$941K
6,056
NASDAQ
RGEN
Repligen
KURIYEL RALF
/
officer: Senior VP, R&D
03/03/2025
Sell
$155.38
386
$60K
16,062
NASDAQ
RGEN
Repligen
KURIYEL RALF
/
officer: Senior VP, R&D
03/03/2025
Buy
$155.38
4,542
$706K
4,542
NASDAQ
RGEN
Repligen
Hunt Anthony
/
director
03/03/2025
Sell
$155.38
10,142
$1.576M
136,301
NASDAQ
RGEN
Repligen
Bylund James
/
officer: Chief Operating Officer
03/03/2025
Sell
$155.38
1,239
$193K
23,959
NASDAQ
RGEN
Repligen
Bylund James
/
officer: Chief Operating Officer
03/03/2025
Buy
$155.38
6,056
$941K
6,056
NASDAQ
RGEN
Repligen
Loeillot Olivier
/
director, officer: Chief Executive Officer
03/03/2025
Buy
$155.38
13,627
$2.117M
13,627
NASDAQ
RGEN
Repligen
Garland Jason K
/
officer: CFO
02/27/2025
Sell
$156.54
316
$49K
7,360
NASDAQ
RGEN
Repligen
Loeillot Olivier
/
director, officer: Chief Executive Officer
02/27/2025
Sell
$156.54
343
$54K
32,213
NASDAQ
RGEN
Repligen
Bylund James
/
officer: Chief Operating Officer
02/27/2025
Sell
$156.54
1,285
$201K
18,763
NASDAQ
RGEN
Repligen
KURIYEL RALF
/
officer: Senior VP, R&D
02/27/2025
Sell
$156.54
391
$61K
11,622
NASDAQ
RGEN
Repligen
Hunt Anthony
/
director
02/27/2025
Sell
$156.54
2,825
$442K
146,443
NASDAQ
RGEN
Repligen
KURIYEL RALF
/
officer: Senior VP, R&D
02/24/2025
Sell
$164.74
275
$45K
12,013
NASDAQ
RGEN
Repligen
Bylund James
/
officer: Chief Operating Officer
02/24/2025
Sell
$164.74
543
$89K
20,048
NASDAQ
RGEN
Repligen
Hunt Anthony
/
director
02/24/2025
Sell
$164.74
2,380
$392K
149,268
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.